Related Experiment Video
Updated: Aug 12, 2025

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
IARC-NCI workshop on an epidemiological toolkit to assess biases in human cancer studies for hazard identification:
Mary K Schubauer-Berigan1, David B Richardson2, Matthew P Fox3
1Evidence Synthesis and Classification Branch, International Agency for Research on Cancer, Lyon, France BeriganM@iarc.fr.
No abstract available in PubMed .
More Related Videos
11:38High Content Screening Analysis to Evaluate the Toxicological Effects of Harmful and Potentially Harmful Constituents HPHC
Published on: May 10, 2016
07:41Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
Published on: May 17, 2019
Related Concept Videos
Bias in Epidemiological Studies
Hazard Ratio
For example, in a clinical trial...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Criteria for Causality: Bradford Hill Criteria - II
Strategies for Assessing and Addressing Confounding
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
Statistical Methods for Analyzing Epidemiological Data